Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Wilkinson

Showing results (891-900 of 1,086) with videos related to

Pageof 109
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 5, 2006
Pharmacogenetics of plasma efavirenz exposure after treatment discontinuation: an Adult AIDS Clinical Trials Group StudyHeather J Ribaudo, David W Haas, Camlin Tierney, et al.
The American Journal of Geriatric Pharmacotherapy|November 13, 2007
Clinical sedation scores as indicators of sedative and analgesic drug exposure in intensive care unit patientsAndrew L Masica, Timothy D Girard, Grant R Wilkinson, et al.
Medrxiv : the Preprint Server for Health Sciences|June 22, 2026
Prevalence and Clinical Significance of Adult-Onset Cancer Predisposition Variants in Pediatric OncologyJamie L Maciaszek, Victor Pastor Loyola, Taylor Cain, et al.
Leukemia|March 1, 2024
Genomic and global gene expression profiling in pediatric and young adult acute leukemia with PICALM::MLLT10 FusionJingqun Ma, Yen-Chun Liu, Rebecca K Voss, et al.
Veterinary Pathology|April 26, 2017
Temporal Progression of Lesions in Guinea Pigs Infected With Lassa VirusT M Bell, C I Shaia, J J Bearss, et al.
British Journal of Cancer|April 21, 2012
Germline BRCA1 mutations increase prostate cancer riskD Leongamornlert, N Mahmud, M Tymrakiewicz, et al.
British Journal of Cancer|September 29, 2011
BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patientsZ Kote-Jarai, D Leongamornlert, E Saunders, et al.
Frontiers in Health Services|September 11, 2023
The VA National TeleNeurology Program implementation: a mixed-methods evaluation guided by RE-AIM frameworkTeresa M Damush, Jayne R Wilkinson, Holly Martin, et al.
Scientific Data|May 21, 2025
WorkflowHub: a registry for computational workflowsOve Johan Ragnar Gustafsson, Sean R Wilkinson, Finn Bacall, et al.
British Journal of Cancer|February 22, 2014
Frequent germline deleterious mutations in DNA repair genes in familial prostate cancer cases are associated with advanced diseaseD Leongamornlert, E Saunders, T Dadaev, et al.
Pageof 109

Showing results (891-900 of 1,086) with videos related to

Sort By:
Pageof 109
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 5, 2006
Pharmacogenetics of plasma efavirenz exposure after treatment discontinuation: an Adult AIDS Clinical Trials Group StudyHeather J Ribaudo, David W Haas, Camlin Tierney, et al.
The American Journal of Geriatric Pharmacotherapy|November 13, 2007
Clinical sedation scores as indicators of sedative and analgesic drug exposure in intensive care unit patientsAndrew L Masica, Timothy D Girard, Grant R Wilkinson, et al.
Medrxiv : the Preprint Server for Health Sciences|June 22, 2026
Prevalence and Clinical Significance of Adult-Onset Cancer Predisposition Variants in Pediatric OncologyJamie L Maciaszek, Victor Pastor Loyola, Taylor Cain, et al.
Leukemia|March 1, 2024
Genomic and global gene expression profiling in pediatric and young adult acute leukemia with PICALM::MLLT10 FusionJingqun Ma, Yen-Chun Liu, Rebecca K Voss, et al.
Veterinary Pathology|April 26, 2017
Temporal Progression of Lesions in Guinea Pigs Infected With Lassa VirusT M Bell, C I Shaia, J J Bearss, et al.
British Journal of Cancer|April 21, 2012
Germline BRCA1 mutations increase prostate cancer riskD Leongamornlert, N Mahmud, M Tymrakiewicz, et al.
British Journal of Cancer|September 29, 2011
BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patientsZ Kote-Jarai, D Leongamornlert, E Saunders, et al.
Frontiers in Health Services|September 11, 2023
The VA National TeleNeurology Program implementation: a mixed-methods evaluation guided by RE-AIM frameworkTeresa M Damush, Jayne R Wilkinson, Holly Martin, et al.
Scientific Data|May 21, 2025
WorkflowHub: a registry for computational workflowsOve Johan Ragnar Gustafsson, Sean R Wilkinson, Finn Bacall, et al.
British Journal of Cancer|February 22, 2014
Frequent germline deleterious mutations in DNA repair genes in familial prostate cancer cases are associated with advanced diseaseD Leongamornlert, E Saunders, T Dadaev, et al.
Pageof 109